(4,6-Dimethylpyrimidin-2-yl)methanamine dihydrochloride, 95.0%, 5g

(2,2-dimethylcyclopropyl)methanol, 95.0%, 5g

(3aS,8aR)-2-(6-Phenylpyridin-2-yl)-8,8a-dihydro-3aH-indeno[1,2-d]oxazole, 97%, 250mg

2-[(methylcarbamoyl)amino]acetic acid, 97%, 250mg

3-Fluoro-5-iodobenzaldehyde, 95.0%, 250mg

5-(4-(2-(Methyl(pyridin-2-yl)amino)ethoxy)benzyl)thiazolidine-2,4-dione, 98.0%, 1g

(E)-3-(3-Bromo-2,5-dichlorophenyl)acrylic acid, 98%, 500mg

tert.-Butanol, min. 99 %, zur Synthese, 25 l, Weißbl.

Fmoc-(R)-3-Amino-4-(3-methyl-phenyl)-butyric acid, 97%, 5g

Reagenzbehälter Inhalt 50 ml, steril, 20 x 5, 100 Stück, 100 Stück

Ethyl [2,2'-bipyrimidine]-5-carboxylate, 98%, 1g

(3R,4S)-4-(4-bromophenyl)pyrrolidine-3-carboxylic acid, 250mg

4-Methyl-3-(1,3-oxazol-2-yl)aniline, 95%, 500mg